Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

The efficacy and safety of comfrey

Bibliographic Data

ID15090871
AuthorsFelix Stickel (0000-0003-1768-3090, Friedrich-Alexander-Universität Erlangen-Nürnberg, corresponding author), Helmut K Seitz (0000-0001-9467-5815, Heidelberg University)
Year2000
Volume3
Issue4a
Pages501-508
Publication date2000-12-01
Open AccessYes
TypeARTICLE
VenuePublic Health Nutrition (JOURNAL)
Journal identifiersISSN: 1368-9800 • E-ISSN: 1475-2727
PublisherCambridge University Press (CUP) (PUBLISHER)
DOI10.1017/s1368980000000586
PMID11276298
OpenAlexW2149429129
LanguageEN
Citations received3
References cited49

Herbal medication has gathered increasing recognition in recent years with regard to both treatment options and health hazards. Pyrrolizidine alkaloids have been associated with substantial toxicity after their ingestion as tea and in the setting of contaminated cereals have led to endemic outbreaks in Jamaica, India and Afghanistan. In Western Europe, comfrey has been applied for inflammatory disorders such as arthritis, thrombophlebitis and gout and as a treatment for diarrhoea. Only recently was the use of comfrey leaves recognized as a substantial health hazard with hepatic toxicity in humans and carcinogenic potential in rodents. These effects are most likely due to various hepatotoxic pyrrolizidine alkaloids such as lasiocarpine and symphytine, and their related N-oxides. The mechanisms by which toxicity and mutagenicity are conveyed are still not fully understood, but seem to be mediated through a toxic mechanism related to the biotransformation of alkaloids by hepatic microsomal enzymes. This produces highly reactive pyrroles which act as powerful alkylating agents. The main liver injury caused by comfrey ( Symphytum officinale ) is veno-occlusive disease, a non-thrombotic obliteration of small hepatic veins leading to cirrhosis and eventually liver failure. Patients may present with either acute or chronic clinical signs with portal hypertension, hepatomegaly and abdominal pain as the main features. Therapeutic approaches include avoiding intake and, if hepatic failure is imminent, liver transplantation. In view of the known serious hazards and the ban on distributing comfrey in Germany and Canada, it is difficult to understand why comfrey is still freely available in the United States

Environmental health · Complementary and Alternative Medicine Studies · Medicine · Plant Toxicity and Pharmacological Properties

  • Analysis of herbal teas made from the leaves of comfrey (Symphytum officinale)

    Open Access•Nicholas H Oberlies, Nam-Cheol Kim et al.•Public Health Nutrition•2004

  • Medicinal plants used for musculoskeletal disorders in Navarra and their pharmacological validation

    Open Access•Rita Yolanda Cavero, María Isabel Calvo•Journal of Ethnopharmacology•2015

  • Skin microbiota metabolism of natural products from comfrey root (Symphytum officinale L.)

    Open Access•Natalia Melnyk, Dominik Popowski et al.•Journal of Ethnopharmacology•2024

Citations per year0.14
Citation span2004 - 2024 (21)
Highly citedNo

Tools

Open DOISci-HubOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae